最新报道:According to Bijie.com, Processa Pharmaceuticals (NASDAQ: PCSA) announced today, August 7, that it has secured strategic investment and plans to incorporate cryptocurrency into its corporate financial management strategy. The company has appointed LifeSci Capital as an advisor to assist with the implementation of this strategy. Processa stated that this decision is intended to diversify its capital structure and enhance financial flexibility. The company will explore the use of blockchain assets to support its clinical development programs, while adhering to strict regulatory standards.